CERO THERAPEUTICS HOLDINGS, INC. Payments to Acquire Restricted Investments
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Payments to Acquire Restricted Investments of $100.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireRestrictedInvestments · last filed 2023-05-12
- CERO THERAPEUTICS HOLDINGS, INC. payments to acquire restricted investments for the quarter ending 2023-03-31 was $100.00K.
- CERO THERAPEUTICS HOLDINGS, INC. payments to acquire restricted investments for the quarter ending 2022-03-31 was $0.00.
- CERO THERAPEUTICS HOLDINGS, INC. payments to acquire restricted investments for fiscal 2022 was $325.00K.
| Period end | Payments to Acquire Restricted Investments 3 month | Payments to Acquire Restricted Investments 7 month | Payments to Acquire Restricted Investments 12 month |
|---|---|---|---|
| 2023-03-31 | $100.00K 10-Q · filed 2023-05-12 | ||
| 2022-12-31 | $325.00K 10-K · filed 2023-03-24 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | ||
| 2021-12-31 | $178.50M 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |